A new scaffold system could transform vascular treatment

Elixir Medical CEO explains how new scaffold system could move vascular treatment beyond the stent

A new scaffold system could transform vascular treatment
(Photo: Devicetalks).
In this episode, Host Tom Salemi learns the Elixir Medical story from Jordanian-American CEO Motasim Sirhan, who has spent most of his medtech career developing new vascular implants to prop open previously occluded blood vessels. Sirhan led developing of early version of bare metal stents while at Guidant. He’d go on to start and sell a company that developed another vascular device before pairing with Invus Group to start Elixir Medical in 2005. اضافة اعلان

After a false start, the company is collecting promising clinical data for its DynamX vascular scaffolding system. We’ll learn why Sirhan sees this as an leap forward from drug-eluting stents. He also shares stories from his career about taking chances and overcoming fears. This episode is sponsored by DeviceTalks West.

Thanks for listening to the DeviceTalks Weekly Podcast.

You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

Listen to more Podcasts
Jordan News